| Entry |
|
|---|
| Name |
Clavulanic acid (INN);
Clavulox (TN) |
|---|
| Formula |
C8H9NO5
|
|---|
| Exact mass |
199.0481
|
|---|
| Mol weight |
199.1608
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Source |
Streptomyces clavuligerus [TAX: 1901]
|
|---|
| Class |
|
|---|
| Remark |
| Product (mixture): | D06485<JP/US> |
|
|---|
| Efficacy |
Antibacterial, Cell wall biosynthesis inhibitor, beta-Lactamase inhibitor |
|---|
| Comment |
Natural product
|
|---|
| Target |
beta-lactamases |
|---|
| Biosynthesis |
|
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01713 Penicillin skeleton group
DG01487 Clavam
DG01261 Clavulanic acid
D07711 Clavulanic acid
DG01479 beta-Lactamase inhibitor
DG01261 Clavulanic acid
D07711 Clavulanic acid
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Beta-lactamase inhibitor
D07711 Clavulanic acid (INN)
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01713 Penicillin skeleton group
DG01487 Clavam
DG01261 Clavulanic acid
DG01479 beta-Lactamase inhibitor
DG01261 Clavulanic acid
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Beta-lactamase inhibitor
DG01261 Clavulanic acid
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 14
1 C1x C 21.2100 -16.5200
2 C5x C 21.2100 -17.9200
3 N1y N 22.6100 -17.9200
4 C1y C 22.6100 -16.5200
5 C1y C 23.9400 -18.3400
6 C2y C 24.7800 -17.2200
7 O2x O 23.9400 -16.1000
8 C6a C 24.4300 -19.6700
9 O6a O 25.8300 -19.6700
10 O6a O 23.5900 -20.7900
11 O5x O 20.0200 -18.6200
12 C2b C 26.1800 -17.2200
13 C1b C 26.8800 -15.9600
14 O1a O 28.2800 -15.9600
BOND 15
1 1 2 1
2 2 3 1
3 3 4 1
4 1 4 1
5 3 5 1
6 5 6 1
7 6 7 1
8 4 7 1
9 5 8 1 #Down
10 8 9 1
11 8 10 2
12 2 11 2
13 6 12 2
14 12 13 1
15 13 14 1
|
|---|
